12.27.2016
By Rob Daly

Outlook 2017: Robert Dykes, Tora

This entry is part 9 in the series Outlook 2017
 

Robert Dykes is CEO of OEMS-provider Tora.

What do you see as the major trend for 2017?

For the past few years, participants across the capital markets have been working to get a better handle on their revenues and costs across counterparties. Part of this is just smart fiscal management, but a variety of external factors like general business model pressures, increased compliance and technology costs, a contraction of trading volumes have certainly accelerated the trend. The result has been open and honest conversations between brokers, vendors, and the buy side about which services are being provided, their costs, and who will pay for them. And that’s a good thing: Opaque, bundled pricing models are in no one’s best interest.

Robert Dykes, Tora

Robert Dykes, Tora

Consequently, although it can be difficult to determine since their vendors are often paid indirectly through several different mechanisms, the buy side is increasingly getting a handle on the true total cost of ownership (TCO) of their trading technology stack. In many cases, that knowledge has been eye-opening, to say the least, with a slew of ancillary fees that their brokers have historically paid for, such as connectivity, BCP, market data, and etc.- coming to light.

We see this trend continuing to accelerate in 2017, with pending regulatory changes like MiFID II potentially pushing this past a tipping point in 2017. Several leading investment management firms have begun talking about which services will be paid for via the client commission pool and that will be considered a cost of doing business and paid for via their own accounts. If more buy-side firms start moving these charges to their own accounts, we see this cost focus becoming one of the most significant trends of the year.

(Visited 84 times, 1 visits today)

Other articles

  1. Machines 'Learn' Liquidity

    The association intends to publish bond liquidity trackers quarterly.

  2. Changes In Research Payments to Impact Independents Least

    Two of three fund managers expect equal or greater outlays under MiFID II.

  3. MiFID II Still Tops Regulatory Agenda

    'Best ex', dark trading and dual-listed shares are among issues.

  4. Recordkeeping Requirement Irks OTC Industry

    MiFID II requires OTC derivatives to have a product reference number.

  5. Contributors Corner

    Hockey Fans Don't Need Regulation

    Blueshirts game prompts the STA's Jim Toes to ponder finreg.